Material Safety Data Sheet Section 1. Identification of the substance Product Name: 4-Methoxy-2,5-dimethylphenylboronic acid Synonyms: Section 2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. Section 3. Composition/information on ingredients. Ingredient name: 4-Methoxy-2,5-dimethylphenylboronic acid CAS number: 246023-54-1 Section 4. First aid measures Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Section 5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section 6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution: Wear approved mask/respirator Hand precaution: Wear suitable gloves/gauntlets Skin protection: Wear suitable protective clothing Eye protection: Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section 7. Handling and storage Handling: This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Store in closed vessels. Storage: Section 8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section 9. Physical and chemical properties Appearance: Not specified Boiling point: No data No data Melting point: Flash point: No data Density: No data Molecular formula: C9H13BO3 Molecular weight: 180.0 Section 10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide. Section 11. Toxicological information No data. Section 12. Ecological information No data. Section 13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section 14. Transportation information Non-harzardous for air and ground transportation. Section 15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313.
Palladium-Catalyzed Monoselective Halogenation of CH Bonds: Efficient Access to Halogenated Arylpyrimidines using Calcium Halides
作者:Bingrui Song、Xiaojian Zheng、Jun Mo、Bin Xu
DOI:10.1002/adsc.200900778
日期:2010.2.15
A wide variety of ortho-halogenated arylpyrimidines were prepared with high monoselectivity and functional-group tolerance by usingcalciumhalides as crucial halogenating agents and cupric trifluoroacetate as oxidant in the presence of air.
first time with arylboronicacids as nucleophiles. This transition‐metal‐free coupling between chiral α‐aryl‐α‐mesylated acetamides and arylboronicacids provided access to a series of chiral α,α‐diaryl acetamides with excellent enantioselectivity and moderate to good yields. The CONH functionality proved to be crucial for bridging the reactants and promoting the reaction. Efficient syntheses of a cannabinoid
[EN] PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION<br/>[FR] PYRAZINONES PYRIDINO ET PYRIMIDINO DESTINEES AU TRAITEMENT DE L'ANXIETE ET DE LA DEPRESSION
申请人:BRISTOL MYERS SQUIBB PHARMA CO
公开号:WO2004031189A1
公开(公告)日:2004-04-15
The present invention provides compounds of Formula (I): wherein the variables A, B, Ar, R1, R2, and R3 are as defined herein. The compounds of Formula (I) can function as corticotropin releasing factor (CRF) receptor antagonists and can be useful, for example, in the treatment of disorders characterized by abnormal levels of CRF such as anxiety and depression.
Mn(<scp>ii</scp>)/O<sub>2</sub>-promoted oxidative annulation of vinyl isocyanides with boronic acids: synthesis of multi-substituted isoquinolines
作者:Hao Wang、Yang Yu、Xiaohu Hong、Bin Xu
DOI:10.1039/c4cc06427e
日期:——
An efficient manganese(II)/O2-promoted oxidative radical cascade reaction was developed for the modular synthesis of multi-substituted isoquinolines from easily accessible vinyl isocyanides and boronic acids.
Synthesis and structure–activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists
作者:Carolyn D. Dzierba、Thais M. Sielecki、Argyrios G. Arvanitis、Amy Galka、Tricia L. Johnson、Amy G. Takvorian、Maria Rafalski、Padmaja Kasireddy-Polam、Shikha Vig、Bireshwar Dasgupta、Ge Zhang、Thaddeus F. Molski、Harvey Wong、Robert C. Zaczek、Nicholas J. Lodge、Andrew P. Combs、Paul J. Gilligan、George L. Trainor、Joanne J. Bronson、John E. Macor
DOI:10.1016/j.bmcl.2012.06.034
日期:2012.8
Pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones were evaluated as corticotropin-releasing factor-1 receptor antagonists. The synthesis, SAR studies and pharmacokinetic evaluation of these analogs are described herein.
Pyrido [3,2 - b ] pyrazin-3(4 H)-one和pteridin-7(8 H)-one被评估为促肾上腺皮质激素释放因子1受体拮抗剂。这些类似物的合成,SAR研究和药代动力学评估在本文中描述。